Fundraising Fox
BioAdvance
Venture capitalConshohocken · Pre-Seed–Late Stage · 19 people tracked
Find your way into BioAdvance
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kuan Yu to introduce you to Frederick "Rick" Jones
You →Kuan · together at BioAdvance →Frederick
Ask Jamie Chen to introduce you to Gregory Harriman
You →Jamie · together at BioAdvance →Gregory
Ask Sam Okafor to introduce you to David Shin
You →Sam · together at BioAdvance →David
- Marnie McCoy147 people can intro you
- Shinichi Miyake61 people can intro you
- Robert Driscoll3 people can intro you
Sign up to find every way you can get introduced to BioAdvance
- Your email: who you already know at BioAdvance, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioAdvance team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
BioAdvance backs early-stage life-science companies in the U.S. Mid-Atlantic region with the potential to enhance human well-being and quality of life. Structured as an evergreen fund, it takes a long-term investment perspective and continues to grow and reinvest over time. Its portfolio companies span therapeutics, medical devices, diagnostics, and digital health, and collectively have attracted over $4.4 billion of external follow-on capital to support their growth.
Source: firm website, verified Sep 27, 2026.
Team · 19 people
from the firm's website & curated & public directories
What they invest in
from 45 of 67 portfolio companiesBiotech ×34Healthtech ×23Medical Devices ×13Digital Health ×9Deep Tech ×8AI & Machine Learning ×7SaaS ×4Cybersecurity ×2
HQs:United States×39United Kingdom×1Italy×1
Who they back
founder profiles across 24 portfolio companiesFounding team size:solo founder×152 founders×83 founders×1
Where their founders studiedfrom 18 founders with education data
Princeton University ×3The Wharton School ×3University of Pennsylvania ×3
What their founders studiedfrom 17 founders with field-of-study data
Life Sciences ×7Economics ×4Computer Science ×3Business & Management ×2Medicine ×2
Where their founders worked beforefrom 16 founders with career history
Harvard John A. Paulson School of Engineering and Applied Sciences ×2
Investments · 67 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 12024 · 12023 · 12022 · 32021 · 12020 · 12019 · 12018 · 22017 · 52016 · 12015 · 123 dated
Immunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer.
BiotechHealthtechExton, US
Scott K. Dessain(Executive Officer, Director)inDennis H Giesing(Executive Officer)inCorleen Roche(Executive Officer)inMichael J Morin(Executive Officer)Purnanand Sarma(Executive Officer, Director)inGeorge Hobbs(Executive Officer)
Co-investorsDelaware Crossing Investor GroupEvolution VC PartnersMilitia Hill VenturesPivotal Life SciencesRobin Hood VenturesT. Rowe Price
Palvella Therapeutics develops QTORIN™, a targeted topical formulation of rapamycin designed to treat rare skin diseases including microcystic lymphatic malformations and cutaneous venous malformations by delivering the active ingredient to the dermal layers with minimal systemic absorption.
BiotechDigital HealthHealthtechMedical DevicesWayne, US
Wesley H. Kaupinen(President, Chief Executive Officer and Director)Matthew E. Korenberg(Chief Financial Officer, Treasurer and Secretary)inKathleen Goin(Chief Operating Officer)inJeffrey Martini(Chief Scientific Officer)inAshley Kline(Chief Commercial Officer)in
Co-investorsFrazier Life SciencesSamsara BioCapitalAgent Capital
QR Pharma is a clinical-stage biopharmaceutical company developing buntanetap, an orally administered small molecule that inhibits the synthesis of multiple neurotoxic proteins implicated in Alzheimer's disease and Parkinson's disease.
BiotechBerwyn, US
Maria Maccecchini(Executive Officer, Director)
BoardDhesh Govender(Director)Michael Hoffman(Director)Franz F. Hefti(Director)
Co-investorsKeiretsu ForumBen Franklin Technology PartnersRobin Hood Ventures
Relmada is a clinical-stage biopharmaceutical company developing therapies including NDV-01, a sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, and Sepranolone, a candidate targeting compulsive behaviors via GABAA receptor modulation.
BiotechHealthtechNew York, US
Sergio Traversa(Executive Officer, Director)Paul Kelly(Director)Maged Shenouda(Director)inEliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Ence(Chief Accounting and Compliance Officer)
Co-investorsBAM ElevateBraidwellCommodore CapitalJanus Henderson InvestorsOrbiMedRA Capital+2 more
RiboNova is a biopharmaceutical company developing small molecule drugs and precision medicines targeting transfer RNA for the treatment of mitochondrial disease.
BiotechDeep TechMedical DevicesWynnewood, US
Co-investorsMilitia Hill Ventures
Accelerated Biosciences commercializes human trophoblast stem cells (hTSC) and derived platforms for therapeutic development, serving pharmaceutical and biotech partners seeking accelerated pathways to clinical products.
BiotechHealthtechMedical Devices
Atalan Tech develops clinician retention intelligence solutions for healthcare systems and organizations seeking to identify at-risk clinicians early, understand underlying causes of burnout and turnover, and implement targeted interventions to improve workforce sustainability.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechHR TechCalifornia, US
Tiffany ChaninSisi HuinTim Russo(Senior Healthcare Technology Executive)inSteven Strongwater(Director)Bob Saunders(Director)B. Bobby Bahram(Director)
Co-investorsBroad Street AngelsEarly Light VenturesExcelerate Health VenturesVTC VenturesOCA Ventures
Bainbridge Health provides software solutions for hospital pharmacy operations, including infusion safety analytics, IV formulation management, and drug library development.
Data & InfrastructureDigital HealthEnterprise SoftwareHealthtechMedical DevicesPhiladelphia, US
Sam Wilson(Executive Officer)inJoseph Kaupp(Executive Officer, Director)Sean O'Neill(Executive Officer, Director)
BoardAmy Gallagher(Director)Shahram Hejazi(Director)Thomas Lynch(Director)
Co-investorsAlumni VenturesChestnut Street Ventures
Concarlo Therapeutics develops cancer therapeutics that target CDK4/6-driven cell proliferation and CDK2-driven resistance, focusing on improving outcomes for cancer patients through novel approaches in p27 biology.
BiotechBrooklyn, US
Stacy Blain(Founder, CEO)inLisaMarie Casey(President and Manager)
BoardJason Mraz(Executive Board Member)in
Co-investorsCreative Destruction Lab (CDL)Raptor Group
Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.
BiotechDigital HealthMedical Devices
Co-investorsMilitia Hill VenturesBen Franklin Technology Partners
ENB Therapeutics develops small molecules targeting the endothelin B receptor (ETBR) in the tumor microenvironment to treat drug-resistant cancers by restoring immune cell infiltration and promoting tertiary lymphoid organ formation.
BiotechHealthtechNew York, US
Sumayah Jamal(President, Co-founder & Chief Scientific Officer)inRobert Schneider(Co-founder & Chair of Scientific Advisory Board)inSandy Harm(Chief Operating Officer)inFumitaka Mori(Director)Albert Sokol(Executive Officer)
BoardBarbara Schilberg(Director)
Co-investorsAvestria VenturesRemiges Ventures, Inc.
One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Christina Lopes(Co-Founder & CEO)inBenjamin Lewis(Co-Founder)inchristina lopes(Founder)in
Co-investorsAndreessen HorowitzaVentureCivilization Ventures Management, LlcGlobal BrainIKJ CapitalMaC Venture Capital+13 more
Hanimune Therapeutics develops therapeutics for food allergy prevention and tolerance support for pediatric and adult patients, drawing on immunological science and food protein research.
BiotechFoodTechHealthtechMedical Devices
Meenal Lele(Founder)in
Co-investorsRobin Hood Ventures
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company developing immune therapies for immune-excluded tumors, which resist standard PD-1 blockade.
BiotechHealthtechMedical DevicesDoylestown, US
Michael A. Curran(Director)inJennifer Barlow(Executive Officer, Director)Clifford Stocks(Director)James Barlow(Executive Officer, Director)Jeremy Barton(Executive Officer)Federica O'Brien(Executive Officer)
Co-investors3Spoke CapitalAdit Ventures Management, LlcAngel Physicians FundCancer FocusService Provider CapitalTexas HALO Fund
BiotechNew York, US
Nader Halim(Executive Officer, Director)Althea Stillman(Executive Officer, Director)
BoardJonathan Leff(Director)David Greenwald(Director)in
Co-investorsDeerfield Management Company
BiotechCranbury, US
Bo Liang(Executive Officer, Director)Houman Hemmati(Executive Officer, Director)Wei Wang(Executive Officer, Director)John J Baldwin(Director)Tao Du(Director)
BoardQi Zhu(Director)
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Co-investorsBioGenerator VenturesDelaware Crossing Investor GroupMaryland TEDCONYBC VenturesOld Line Capital PartnersTEDCO+1 more
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investors7G BioVenturesFoundation Venture Capital Group, LLC
Keriton offers a software platform for neonatal and pediatric hospital settings that supports safe infant feeding practices, milk management (donor human milk, formula, and parental human milk), and family engagement through features like secure photo sharing, e-journaling, and clinician messaging.
BiotechDigital HealthHealthtechSaaSPhiladelphia, US
Vidur Shailendra Bhatnagar(Manager)
Co-investors37 AngelsBroad Street AngelsDorm Room
Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise.
AI & Machine LearningBiotechDeep TechHealthtechPhiladelphia, US
Co-investorsHatch BioFund8VCDCVC (Data Collective)DCVC BioGaingelsKorea Development Bank+1 more
__Twitter.png)
Latus develops gene therapies based on novel AAV capsid variants matched to optimized routes of administration, aiming to target specific cell types and tissues to lower dose requirements, toxicity, and manufacturing costs.
AI & Machine LearningBiotechDeep Tech
Co-investors8VCDCVC (Data Collective)Modi Ventures
Loudmark is a marketing and design agency that provides advertising, branding, graphic design, web development, event production, and packaging services to clients.
AdTechMarketing TechPeachtree City, US
Co-investorsFitz Gate Ventures
Melior Discovery provides in vivo pharmacology services and phenotypic screening platforms for pharmaceutical and biopharmaceutical companies to evaluate candidate therapeutics in animal disease models.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Andrew Reaume(President and CEO, Co-Founder)inAndrew Reaume, PhD, MBA(President and CEO, Co-Founder)
HealthtechWilmington, US
Christopher Berlind(Executive Officer, Director)inDavid Lindsay, Jr.(Executive Officer, Director)
BoardGary Kurtzman(Director)
Co-investorsCota CapitalDorm Room
Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier.
BiotechDeep TechHealthtech
Frank S Walsh(CEO (Founder))J Lynn Rutkowski(CSO (Founder))inSteve Moore(COO)inPawel Stocki(VP Research)in
Phrase Health provides analytics tools for health systems to reduce unwarranted clinical variation within the electronic health record (EHR), aiming to lower costs and improve patient outcomes.
Digital HealthHealthtechSaaSPhiladelphia, US
Marc Tobias, MD, FAMIA(Founder)inMichael Zeidlhack(Executive Officer, Director)Marc Tobias(Founder)inNaveen Muthu(Director)in
Co-investorsLionBird
Ermit designs and manufactures connected hardware devices with embedded software and AI capabilities, serving companies building IoT and field-operated products.
CybersecurityHardwareIoTNew York, IT
Emanuele Musini(CEO and Director)James Wyman(CFO and Director)
BoardYogendra Jain(Director)
Co-investorsCivilization Ventures Management, LlcHackensack Meridian Health Bear's DenHikma VenturesSamsung VenturesStanley Ventures
BiotechGreenwhich, US
Wendy DiCicco(Ms. DiCicco is the Secretary and Treasurer of the Issuer.)inArthur Feldman(Director)Magdalene Cook(Executive Officer, Director)Campbell Murray(Director)Edward J. Benz, Jr.(Director)Thomas Needham(Director)in
Co-investorsBroadview VenturesElysia CapitalInnogest CapitalNew Leaf Venture PartnersNovartis Venture Fund
Ride Health connects healthcare organizations with transportation services to ensure patients, particularly older adults and people with disabilities, can reliably access medical care.
B2B MarketplacesHealthtechLogistics & Supply ChainSaaSSan Francisco, US
Imran Cronk(Founder)inDaniel Faath(Executive Officer, Director)Michael Reardon(Executive Officer)Cindy Nguyen(Executive Officer)
BoardTodd Pietri(Director)inSamir Malik(Director)
Co-investorsExcelerate Health VenturesTopmark PartnersActivate Venture PartnersActivate VenturesBridge BankLeading Edge Ventures+2 more
Spirovant is a gene therapy company developing treatments for cystic fibrosis and other respiratory diseases, including viral vector-based therapies for airway epithelia.
BiotechHealthtechPhiladelphia, US
Joan Lau(Co-founder & Chief Executive Officer)Eric Yuen(Co-founder & Chief Medical Advisor (former CMO))inJane Hollingsworth(Co-founder & Executive Chair of the Board)inRoland Kolbeck(Chief Scientific Officer & Co-owner)inEric Pastor(Chief Technology Officer)inDavid Whitwell(Chief Financial Officer)in
Co-investorsMilitia Hill Ventures
Strados Labs builds wearable biosensors and a cloud platform that continuously capture and analyze respiratory data — including cough, spirometry, FeNO, and eCOA endpoints — in patients' daily lives.
AI & Machine LearningBiotechDigital HealthMedical DevicesPhiladelphia, US
Nick Delmonico(CEO & Co-founder)Yu Kan Au(Clinician Co-founder)Richard Powers(Executive Officer, Director)Steve Bishop(Director)Robert Ball(Director)Alex Levit(Director)
Co-investorsBand of AngelsBrincBroad Street AngelsCathexis VenturesNeer Venture PartnersNextFab Ventures+3 more
Tolerance is a compliance platform that runs continuous automated checks against the NIST 800-171 standard and collects assessor-ready evidence for teams handling Controlled Unclassified Information (CUI).
CybersecurityGovTechSaaS
Co-investorsDorm RoomAmadeus Capital PartnersBen Franklin Technology PartnersColumbus Venture PartnersCriteria Bio VenturesEast Innovate+5 more
Tolerance Bio develops therapeutics targeting the thymus—the regulator of immune tolerance—to preserve, restore, and manipulate its function and extend health span.
BiotechDeep TechLongevityPhiladelphia, US
Francisco Leon(Executive Officer, Director)inPhilip Ball(Executive Officer, Director)Justin Vogel(Executive Officer, Director)in
BoardDamia Tormo Carulla(Director)Pablo Cironi(Director)inRobert Goldstein(Director)
Co-investorsCriteria Bio VenturesBen Franklin Technology PartnersColumbus Venture Partners
Developing ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor combination for complicated urinary tract infections.
BiotechMalvern, US
Christopher J. Burns(Executive Officer, Director)Daniel C. Pevear(Executive Officer)Michael Diem(Director)Vincent J. Milano(Director)Ezra Felker(Executive Officer)Shelley Chu(Director)
Co-investorsAMR Action FundForesite CapitalVersant Ventures
Vesteck develops medical device technology in the cardiovascular/endovascular space.
HealthtechMedical DevicesWest Chester, US
JOSEPH W. RAFFERTY(Executive Officer, Director, Promoter)inRafferty Joseph(Executive Officer, Director)inEdward Wulfman(Executive Officer)John Edoga(Director)JOHN DIEDERICH(Director)THIERRY RICHARD(Director)
Co-investorsNew World AngelsOcean Azul PartnersRobin Hood Ventures
Vittoria develops immunotherapies, specifically CAR T-cell therapies, to treat difficult-to-treat diseases including cancers beyond B-cell types.
BiotechDeep TechMedical DevicesPhiladelphia, US
Nicholas Siciliano(Director)inPreston Noon(Executive Officer)
BoardGeeta Vemuri(Executive Officer, Director)Bruce Peacock(Executive Officer, Director)Leon Moulder(Director)
Co-investorsAgent CapitalGlobal BioAccess FundHatch BioFund
Wellsheet builds a clinical workflow support system that uses machine learning to predict physicians' information needs and present a structured, comprehensive view of patient data at the point of care.
AI & Machine LearningDigital HealthHealthtechNew York, US
Craig Limoli(Executive Officer, Director, Promoter)inDaniel Larkin(Executive Officer, Director, Promoter)
Co-investorsBeni Venture CapitalReal-Life InnovationsREDO VenturesSpringTide VenturesNewark Venture PartnersNVP Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Acuity PharmaceuticalsAggamin BiologicsAlleviAlterisAnnovisAvid RadiopharmaceuticalsBobcatBioCeptarisCohero HealthCrossBridgeHalo LabsHealthQxHueDxImmuneInfraScanIntezyneLadder BioLumenVuMebias DiscoveryMidway PharmaceuticalsNovira TherapeuticsNuPatheOnspira TherapeuticsOpsidioPalvella TherapeuticsProtez PharmaceuticalsSenzoStradosThe One Health CompanyTreventis
Exits · 5
4 IPOs · 1 acquisitionsImmunomeNASDAQ: IMNMPalvellatxNASDAQ: PVLAQR PharmaNYSE: ANVSRelmada TherapeuticsNASDAQ: RLMDNovira Therapeuticsacq. by Johnson & Johnson (Janssen)
Portfolio news
latest coverage across their companiesImmunome · stocktitan.net · Aug 14, 2026
Latus · finsmes.com · May 5, 2026
Frequently asked questions
- How many investments has BioAdvance made?
- BioAdvance has 67 tracked investments, 5 of which have exited, including 5 dated in the last 24 months.
- What stage does BioAdvance invest at?
- BioAdvance invests at the Pre-Seed, Seed, Series A, Late Stage stages.
- What is BioAdvance's typical check size?
- BioAdvance typically writes checks of $500K – $1.5M.
- What sectors does BioAdvance focus on?
- BioAdvance focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is BioAdvance located?
- BioAdvance is headquartered in Conshohocken, US.
- Does BioAdvance lead rounds?
- Yes, BioAdvance leads investment rounds.
- Who does BioAdvance co-invest with?
- BioAdvance most often shares deals with Robin Hood Ventures, Broad Street Angels, Militia Hill Ventures, among 67 tracked co-investors.
Media · Podcasts & interviews
featuring the teamShahram Hejazi & Rick Jones of BioAdvance - 2020 Speaker Series - January 30th
Jefferson Innovation · Shahram Hejazi
Images
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.